bpc 157 recommended dosage for regeneration BPC-157 Dosing (Common Protocols), ๐น Oral / Subcutaneous, โข 500 mcg daily, โข Duration: 6 weeks, ๐น Intramuscular / Peritendinous, โข 1 mg daily, โข Duration: 6 weeks, โ ๏ธ Note:, Not approved by FDA or BPC-157 Uncovered - The Definitive
Description
When given intraperitoneally (i.e., 10 g/kg b.w.), NaBPC157 was shown to prevent the development of alloxan as well as streptozotocin induced diabetes in rats
Regular follow-up visits will be crucial for eventually evaluating the effectiveness and safety of the combined therapy
Dauer der Anwendung: Das Arzneimittel ist zur lngeren Anwendung bestimmt
No cardiovascular signals
